WINDTREE THERAPEUTICS INC /DE/

WINT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-39.5M $-55.2M $-44.1M $-45.2M $-37.3M $-21.0M $-19.2M
Depreciation & Amortization $255.0K $712.0K $818.0K $707.0K $1.2M $1.2M $1.5M
Depreciation $300.0K $700.0K $800.0K $700.0K $900.0K $1.3M $1.4M
Amortization
Stock-Based Compensation
Net Cash from Operating Activities $-33.6M $-33.5M $-41.2M $-40.5M $-32.9M $-22.7M $-24.3M
Investing Activities
Capital Expenditures $281.0K $458.0K $780.0K $608.0K $636.0K $106.0K $101.0K
Business Acquisitions
Net Cash from Investing Activities $-254.0K $-608.0K $-636.0K $-106.0K $-101.0K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $709.0K $100.5M $50.2M $22.8M $18.8M
Net Change in Cash $-33.1M $-6.0M $-41.6M $59.4M $16.7M $-22.0K $-5.5M
Free Cash Flow $-33.9M $-34.0M $-41.9M $-41.1M $-33.5M $-22.8M $-24.4M
← Newer Page 2 of 2 Older →